27.11.2013 16:54:00
|
CVS/Caremark Corp. -- Moody's: CVS Caremark's agreement to purchase Coram has positive credit implications
New York, November 27, 2013 -- Moody's Investor's Service today stated that CVS Caremark Corp. agreement to buy Coram LLC, the specialty infusion services and enternal nutrition business from Apria Healthcare Group Inc for about $2.1 billion is a credit positive. However, there is no current impact to its Baa1 senior unsecured rating or stable outlook.